source
- Geopolitics ‘chills’ British biotech IPO plans, despite $2B in Q2 VC fundsGeopolitical uncertainty has continued to “chill” IPO sentiment among British biotechs, an industry leader has told Fierce, even as the sector saw second-quarter venture capital funding reach a fiv…Fierce Biotech · 11d ago↗ source
- Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businessesAbbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses.Fierce Biotech · 11d ago↗ source
- Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with RanitidineFOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hyd…